Accession Number: | 0001104659-19-072572 |
Date: | 2019-12-13 |
Issuer: | MARINUS PHARMACEUTICALS INC (MRNS) |
Original Submission Date: |
BRAUNSTEIN SCOTT
C/O MARINUS PHARMA, 5 RADNOR CORP CENT,
100 MATSONFORD RD SUITE 500
RADNOR, PA 19087
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-12-13 | P | 100,000 | a | $1.25 | 100,000 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|